IRADIMED Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for IRADIMED CORPORATION (IRMD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income19.2317.1912.839.331.379.636.30
Depreciation & Amortization0.820.770.671.411.341.241.11
Deferred Income Tax-0.70-1.170.060.520.000.00-0.14
Stock Based Compensation2.522.191.391.463.960.000.00
Change in Working Capital3.75-5.91-5.06-1.58-1.17-2.94-1.81
Change in Accounts Receivable1.760.84-8.24-0.582.690.000.00
Change in Inventory3.13-7.47-1.31-0.39-0.280.000.00
Change in Accounts Payable-0.86-0.221.120.07-0.400.000.00
Change in Other Working Capital-0.280.06-0.210.14-2.060.000.00
Other Operating Activities0.00-0.990.110.640.301.940.00
Net Cash from Operating Activities25.6213.4710.0411.265.8210.237.38
Investing Activities
Capital Expenditures-8.01-7.44-0.82-0.74-0.440.49-0.04
Purchases of Investments0.000.000.501.390.880.000.00
Sales/Maturities of Investments0.00-0.57-1.051.39-0.193.691.78
Other Investing Activities-0.810.000.000.000.000.000.00
Net Cash from Investing Activities-8.82-8.01-1.370.650.253.201.52
Financing Activities
Common Stock Issued0.030.180.150.621.730.000.00
Common Stock Repurchased0.00-0.61-0.29-0.60-1.210.000.00
Dividends Paid-13.68-13.22-12.560.000.000.000.00
Other Financing Activities-0.69-0.61-0.29-0.60-1.21-0.47-0.31
Net Cash from Financing Activities-14.34-13.66-12.710.020.522.020.93
Summary
Net Change in Cash2.47-8.20-4.0411.936.5915.459.82
Cash at Beginning of Period49.7617.1962.0050.0743.4828.0318.21
Cash at End of Period52.2317.1957.9662.0050.0743.4828.03
Free Cash Flow17.626.029.2210.525.379.757.11
Supplemental Disclosures
Income Taxes Paid6.515.351.710.970.000.011.38